Financials
- Market Capitalization 9.82 B
- Employee 295
- Founded 2016
- CEO N/A
- Website www.krystalbio.com
- Headquarter Pennsylvania, United States
- FIGI BBG00HDGRHH7
- Industry 生物技术
总收入
净利润
每股基本收益(基本 EPS)
总债务
自由现金流
现金及现金等价物
市盈率
36.04
市销率
18.98
Related tickers
| # | 姓名 | 价格 | 24小时 % | 7天 % | 一个月 % | 一年 % | 市值 | 最近7天 | |
|---|---|---|---|---|---|---|---|---|---|
| 859 | BMRN BioMarin Pharmaceutical Inc. - Common Stock | 54.80 USD | -0.16% | -4.04% | -17.59% | +4.68% | 10.61 B USD | ||
| 890 | KNSA Kiniksa Pharmaceuticals International, plc - Class A Ordinary Shares | 79.78 USD | +1.31% | +5.02% | +2.43% | +101.24% | 10.15 B USD | ||
| 931 | KYMR Kymera Therapeutics, Inc. - Common Stock | 112.40 USD | +2.84% | +3.71% | -3.10% | +90.19% | 9.35 B USD | ||
| 933 | PTGX Protagonist Therapeutics, Inc. - Common Stock | 143.73 USD | +2.73% | +2.04% | -4.13% | +91.31% | 9.30 B USD |